Aalto's bone lengthening treatment spinout Synoste has been snapped up after raising funding from investors including Evonik and Mectalent.

Synoste, a Norway-based orthopaedic bone lengthening technology spinout of Aalto University, has been acquired by medical device manufacturer Globus Medical in a deal enabling specialty chemicals producer Evonik to exit. Founded in 2012, Synoste has created an orthopaedic implant for treating patients with leg length deformities. The implant is made using malleable polymer materials supplied…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.